Can lower drug doses make stem cell transplants safer for seniors?
Disease control
Recruiting now
This study is for people aged 65 and older with blood cancers who are getting a stem cell transplant. Researchers want to see if giving a lower dose of the drug cyclophosphamide after the transplant can reduce serious side effects while still controlling the cancer. The trial wil…
Phase: PHASE1 • Sponsor: Ronald Paquette • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC